ADVERTISEMENT
MicroMatrix®
MicroMatrix® is a medical device manufactured using proprietary MatriStem® UBM (Urinary Bladder Matrix) technology. MicroMatrix offers a wound management solution for irregular, tunneled, or undermined wounds. Applied as either a powder or paste, the particulate solution provides intimate contact with all areas of the wound bed.
Integra LifeSciences Corp.
Integra LifeSciences Corp.
Integra offers innovative solutions in neurosurgery with a broad portfolio of products and solutions for dural access and repair, cerebral spinal fluid management and neuro-critical care. The regenerative tissue technologies portfolio includes products that address soft tissue, nerve and tendon repairs and are used in the treatment of acute and chronic wounds, burns, as well as plastic and reconstructive surgery.
20mg to 1,000mg.
• Supports a healing environment through constructive remodeling
• Comprised of naturally-occurring urinary bladder matrix
• Contains basement membrane and numerous collagens
• Appropriate for acute wounds and chronic wounds
• Maintains an intact epithelial basement membrane
• Non-crosslinked wound management scaffold
MicroMatrix® (particles) are intended for management of topical wounds including: partial- and full-thickness wounds, pressure ulcers, venous ulcers, diabetic ulcers, chronic vascular ulcers, tunneled/undermined wounds, surgical wounds (donor sites/grafts, post-Mohs surgery, post-laser surgery, podiatric, wound dehiscence), trauma wounds (abrasions, lacerations, second-degree burns and skin tears) and draining wounds. The device is intended for one-time use.
Contraindicated for use on patients with known sensitivity or allergy to porcine materials or third-degree burns.
Do not re-use or re-sterilize. Do not use device if package seal has been broken.
Complications and reactions are possible with any soft tissue repair, including but not limited to: infection, increased chronic inflammation, allergic reaction, unexplained fever or chills, excessive redness, pain or swelling.
Store in a clean, dry environment between 15°C-35°C (59°F-95°F) in unopened and undamaged package.
Clean wound according to manufacturer instructions and clinical protocol. Aseptically remove the MicroMatrix® from packaging. Rinse wound with sterile saline. Apply device to wound surface lightly covering the entire wound. Discard any unused portions of device.
Wet wound: Cover MicroMatrix® with non-adherent moist dressing such as petrolatum gauze, followed by application of an absorptive dressing such as a calcium alginate. Secure dressings to wound site.
Dry wound: Cover MicroMatrix® with non-adherent moist dressing followed by application of a hydrogel dressing to keep wound moist. Secure dressings to wound site. Keep dressing and wound bed moist.
Devices are supplied sterile by electron beam irradiation in a vial or container and a peel-open package. Device is sterile if package is unopened and undamaged.
